We are live on
!
Find out more
SC
Schiavi & Co Portfolio holdings
AUM
$378M
1-Year Est. Return
16.22%
This Fund
S&P 500
This Quarter
Est. Return
-0.21%
1 Year Est. Return
+16.22%
3 Year Est. Return
+41.35%
5 Year Est. Return
+31.01%
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$1.29M
(+0.51%)
Cap. Flow
+$1.99M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
96.68%
Holding
37
New
3
Increased
11
Reduced
8
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.55M |
| 2 |
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
|
+$878K |
| 3 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$638K |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$455K |
| 5 |
Microsoft
MSFT
|
+$371K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
|
+$867K |
| 2 |
AstraZeneca
AZN
|
+$770K |
| 3 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$561K |
| 4 |
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
|
+$276K |
| 5 |
Vanguard Extended Market ETF
VXF
|
+$225K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.9% |
| 2 | Technology | 0.72% |
| 3 | Healthcare | 0.6% |
| 4 | Financials | 0.38% |
| 5 | Materials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
| $265K | 0.1% |
4,519
| – | – |
|
27
ExxonMobil
XOM
$696B
| $264K | 0.1% |
2,294
| – | – |
|
28
IBM
IBM
$236B
| $234K | 0.09% |
1,351
| – | – |
|
29
Corteva
CTVA
$56.3B
| $232K | 0.09% |
4,301
| – | – |
|
30
iShares Core S&P 500 ETF
IVV
$836B
| $231K | 0.09% |
423
+33
| +8% | +$17.4K |
|
31
Globus Medical
GMED
$10.1B
| $205K | 0.08% |
+3,000
| New | +$179K |
|
32
Oneok
OKE
$60.5B
| $201K | 0.08% |
+2,468
| New | +$197K |
|
33
NVIDIA
NVDA
$5.11T
| $200K | 0.08% |
+1,620
| New | +$164K |
|
34
E.W. Scripps
SSP
$301M
| $56.8K | 0.02% |
18,087
| – | – |
|
|
35
AstraZeneca
AZN
$253B
| – | – |
-5,686
| Closed | -$770K |
|
36
ConocoPhillips
COP
$170B
| – | – |
-1,583
| Closed | -$202K |
|
|
37
Vanguard Extended Market ETF
VXF
$30.6B
| – | – |
-1,284
| Closed | -$225K |
|
Similar funds
CFCI
SEEDPG
WG
CMP
SWM
JIC
FA
AWA
Schiavi & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Schiavi & Co held 37 positions worth $255M, up 0.51% from $254M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Schiavi & Co's Q2 2024 filing shows 3 new, 11 increased, 8 reduced and 3 closed positions. Its largest new stake was Oneok: 2,468 shares worth $201K. The largest sale was PIMCO RAFI Dynamic Multi-Factor US Equity ETF, an estimated $867K.
By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, down from 98% a quarter earlier, followed by Technology and Healthcare.
- Schiavi & Co's largest Q2 2024 buy was Oneok: 2,468 shares worth $201K.
- Schiavi & Co added most to Vanguard Short-Term Treasury ETF in Q2 2024, an estimated $1.55M increase.
- Schiavi & Co's biggest Q2 2024 reduction was PIMCO RAFI Dynamic Multi-Factor US Equity ETF, cutting an estimated $867K.
- Schiavi & Co fully exited AstraZeneca in Q2 2024, selling an estimated $770K.
- Schiavi & Co's ten largest holdings make up 97% of its $255M portfolio in Q2 2024.
- Schiavi & Co opened 3 new positions and closed 3 in Q2 2024.
- Schiavi & Co's portfolio value rose 0.51% quarter-over-quarter to $255M.
Based on Schiavi & Co's 13F filing for Q2 2024, filed 8 Aug 2024.